These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33770116)

  • 1. GM-1111 reduces radiation-induced oral mucositis in mice by targeting pattern recognition receptor-mediated inflammatory signaling.
    Pulsipher A; Savage JR; Kennedy TP; Gupta K; Cuiffo BG; Sonis ST; Lee WY
    PLoS One; 2021; 16(3):e0249343. PubMed ID: 33770116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.
    Martins AFL; Nogueira TE; Morais MO; Oton-Leite AF; Valadares MC; Batista AC; Freitas NMA; Leles CR; Mendonça EF
    Trials; 2019 Feb; 20(1):97. PubMed ID: 30709370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Damage in Radiation-Induced Oral Mucositis Is Mitigated by IL-17 Receptor Signaling.
    Saul-McBeth J; Dillon J; Lee A; Launder D; Kratch JM; Abutaha E; Williamson AA; Schroering AG; Michalski G; Biswas P; Conti SR; Shetty AC; McCracken C; Bruno VM; Parsai EI; Conti HR
    Front Immunol; 2021; 12():687627. PubMed ID: 34220843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral glutamine: Is there a role in the amelioration of radiation-induced mucositis? A prospective case-control study at a tertiary care centre in North India.
    Fatima K; Andleeb A; Nasreen S; Sofi MA; Najmi AM; Qadri SK; Ryhan R; Roohi S; Afroz F; Khan NA
    J Cancer Res Ther; 2024 Apr; 20(3):858-862. PubMed ID: 38261438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypothesis for the pathogenesis of radiation-induced oral mucositis: when biological challenges exceed physiologic protective mechanisms. Implications for pharmacological prevention and treatment.
    Sonis ST
    Support Care Cancer; 2021 Sep; 29(9):4939-4947. PubMed ID: 33712912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized clinical trial of granulocyte macrophage colony stimulating factor mouthwash for oral mucositis in head and neck cancer.
    Dodd MJ; Cho MH; Cooper BA; MacPhail L; Miaskowski C
    Eur J Oncol Nurs; 2022 Feb; 56():102093. PubMed ID: 35026498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
    Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
    Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Phase 2 Trial of a Novel Clonidine Mucoadhesive Buccal Tablet for the Amelioration of Oral Mucositis in Patients Treated With Concomitant Chemoradiation Therapy for Head and Neck Cancer.
    Giralt J; Tao Y; Kortmann RD; Zasadny X; Contreras-Martinez J; Ceruse P; Arias de la Vega F; Lalla RV; Ozsahin EM; Pajkos G; Mazar A; Attali P; Bossi P; Vasseur B; Sonis S; Henke M; Bensadoun RJ
    Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):320-328. PubMed ID: 31669562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer.
    Iovoli AJ; Turecki L; Qiu ML; Khan M; Smith K; Yu H; Ma SJ; Farrugia MK; Singh AK
    JAMA Netw Open; 2023 Oct; 6(10):e2337265. PubMed ID: 37819659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Effect of Ecdysterone Combine Paeonol Oral Cavity Direct Administered on Radiation-Induced Oral Mucositis in Rats.
    Yang L; Pan J
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confounding factors associated with oral mucositis assessment in patients receiving chemoradiotherapy for head and neck cancer.
    Chung YL; Pui NNM
    Support Care Cancer; 2017 Sep; 25(9):2743-2751. PubMed ID: 28353040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients-a randomized placebo controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Guddattu V
    J Photochem Photobiol B; 2015 Mar; 144():51-6. PubMed ID: 25704314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy.
    Trotti A; Garden A; Warde P; Symonds P; Langer C; Redman R; Pajak TF; Fleming TR; Henke M; Bourhis J; Rosenthal DI; Junor E; Cmelak A; Sheehan F; Pulliam J; Devitt-Risse P; Fuchs H; Chambers M; O'Sullivan B; Ang KK
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):674-81. PubMed ID: 14967419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of Promoter Region of TNFRSF1A Gene (-610 T > G) as a Novel Predictive Factor for Radiotherapy Induced Oral Mucositis in HNC Patients.
    Brzozowska A; Powrózek T; Homa-Mlak I; Mlak R; Ciesielka M; Gołębiowski P; Małecka-Massalska T
    Pathol Oncol Res; 2018 Jan; 24(1):135-143. PubMed ID: 28401452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy-induced severe oral mucositis: pharmacotherapies in recent and current clinical trials.
    Villa A; Sonis ST
    Expert Opin Investig Drugs; 2023 Apr; 32(4):301-310. PubMed ID: 36932830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy--a randomized controlled trial.
    Gautam AP; Fernandes DJ; Vidyasagar MS; Maiya AG; Nigudgi S
    Support Care Cancer; 2013 May; 21(5):1421-8. PubMed ID: 23224689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
    Sunaga T; Nagatani A; Fujii N; Hashimoto T; Watanabe T; Sasaki T
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1317. PubMed ID: 33295153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of dynamic changes in γ-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis.
    Li P; Du CR; Xu WC; Shi ZL; Zhang Q; Li ZB; Fu S
    Radiat Oncol; 2013 Jun; 8():155. PubMed ID: 23803252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Might photobiomodulation therapy interfere with the frequency of severe mucositis and oral candidiasis? A retrospective analysis in patients with head and neck carcinoma.
    Nascimento RB; Neri BP; Moutinho MM; Fortuna T; Martins GB; Carrera M; Lima HR
    Support Care Cancer; 2024 Jul; 32(8):508. PubMed ID: 38992294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
    Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
    Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.